Our predictions are made by artificial intelligence (AI) models trained to predict clinical outcomes from patient data inputs.
Clinical outcomes collected from oncologists include reports of progressive disease, stable disease, partial response, and complete response.
Patient data used as inputs by the AI models include readings from our live-cell drug sensitivity assay, flow cytometry, PARR, and patient information.Models are re-trained periodically to incorporate new data and refine performance.